1 INTRODUCTION

    1.1 Study Objectives
    1.2 Market Definition

        1.2.1 Inclusions and Exclusions

    1.3 Study Scope

        1.3.1 Years Considered

    1.4 Currency Considered
    1.5 Stakeholders

2 MARKET OVERVIEW

    2.1 Introduction
    2.2 Market Dynamics

        2.2.1 Drivers

            2.2.1.1 Expanding companion animal population and pet ownership
            2.2.1.2 Growing concerns about infectious zoonotic diseases
            2.2.1.3 Rising awareness initiatives by government and animal
                    welfare organizations
            2.2.1.4 Increasing adoption of pet insurance and high animal
                    healthcare expenditure

        2.2.2 Restraints

            2.2.2.1 Rising pet care costs
            2.2.2.2 Restrictions on Use of parasiticides for food-producing
                    animals

        2.2.3 Opportunities

            2.2.3.1 Technological advancements and product launches
            2.2.3.2 High growth potential in emerging economies
            2.2.3.3 Surging number of veterinary practitioners in developed
                    markets

        2.2.4 Challenges

            2.2.4.1 Growing resistance to parasiticides
            2.2.4.2 Diversity in parasite species

    2.3 Industry Trends

        2.3.1 Rise in Pet Ownership, Humanization of Pets, and Increased Focus
              on Pet Wellness Programs
        2.3.2 Rising Use of Diagnostics and Wearable Technology for Early
              Detection

    2.4 Technology Analysis

        2.4.1 Key Technologies

            2.4.1.1 Topical nanomedicine
            2.4.1.2 Biologic therapies

        2.4.2 Complementary Technologies

            2.4.2.1 Phototherapy
            2.4.2.2 Hydrotherapy

        2.4.3 Adjacent Technologies

            2.4.3.1 Telemedicine platforms
            2.4.3.2 Wearable devices

    2.5 Porter’s Five Forces Analysis

        2.5.1 Competitive Rivalry

            2.5.1.1 Established players
            2.5.1.2 Continuous innovation

        2.5.2 Bargaining Power of Buyers

            2.5.2.1 Consolidated veterinary groups
            2.5.2.2 Demand for affordable solutions

        2.5.3 Bargaining Power of Suppliers

            2.5.3.1 Specialized raw materials
            2.5.3.2 Quality compliance

        2.5.4 Threat of Substitutes

            2.5.4.1 Limited alternatives
            2.5.4.2 Specialized treatments

        2.5.5 Threat of New Entrants

            2.5.5.1 High R&D costs
            2.5.5.2 Regulatory requirements

    2.6 Patent Analysis

        2.6.1 Patent Publication Trends for Veterinary Dermatology Market
        2.6.2 Insights: Jurisdiction and Top Applicant Analysis

    2.7 Trade Analysis

        2.7.1 Import and Export Scenario for Veterinary Dermatology Products

    2.8 Reimbursement Analysis
    2.9 Key Conferences and Events

3 COMPETITIVE LANDSCAPE

    3.1 Overview
    3.2 Key Player Strategy/Right to Win
    3.3 Revenue Analysis of Key Players in Veterinary Dermatology Market
        (2020–2024)
    3.4 Market Share Analysis, 2024

        3.4.1 Ranking of Key Market Players, 2024

    3.5 Company Evaluation Matrix: Key Players, 2024

        3.5.1 Stars
        3.5.2 Emerging Leaders
        3.5.3 Pervasive Players
        3.5.4 Participants
        3.5.5 Company Footprint: Key Players, 2024

            3.5.5.1 Company footprint
            3.5.5.2 Region footprint
            3.5.5.3 Route of administration footprint
            3.5.5.4 Product type footprint
            3.5.5.5 Condition type footprint
            3.5.5.6 Animal type footprint

    3.6 Brand/Product Comparison
    3.7 R&D Expenditure of Key Players
    3.8 Company Valuation and Financial Metrics

        3.8.1 Company Valuation
        3.8.2 Financial Metrics

    3.9 Competitive Scenario

        3.9.1 Product Approvals/Launches
        3.9.2 Deals
        3.9.3 Expansions
        3.9.4 Other Developments

4 COMPANY PROFILES

    4.1 ELANCO ANIMAL HEALTH INCORPORATED

        4.1.1 Business overview
        4.1.2 Products/Solutions/Services offered
        4.1.3 Recent developments

    4.2 MERCK & CO., INC

        4.2.1 Business overview
        4.2.2 Products/Solutions/Services offered
        4.2.3 Recent developments

    4.3 VIRBAC

        4.3.1 Business overview
        4.3.2 Products/Solutions/Services offered
        4.3.3 Recent developments

    4.4 ZOETIS INC.

        4.4.1 Business overview
        4.4.2 Products/Solutions/Services offered
        4.4.3 Recent developments

    4.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

        4.5.1 Business overview
        4.5.2 Products/Solutions/Services offered
        4.5.3 Recent developments

    4.6 VETOQUINOL

        4.6.1 Business overview
        4.6.2 Products/Solutions/Services offered
        4.6.3 Recent developments

    4.7 DECHRA PHARMACEUTICALS PLC

        4.7.1 Business overview
        4.7.2 Products/Solutions/Services offered
        4.7.3 Recent developments

    4.8 HESTER BIOSCIENCES LIMITED

        4.8.1 Business overview
        4.8.2 Products/Solutions/Services offered
        4.8.3 Recent developments

    4.9 PETIQ, INC.

        4.9.1 Business overview
        4.9.2 Products/Solutions/Services offered
        4.9.3 Recent developments

    4.10 OUROFINO SAUDE ANIMAL

        4.10.1 Business overview
        4.10.2 Products/Solutions/Services offered
        4.10.3 Recent developments

    4.11 SWEDENCARE

        4.11.1 Business overview
        4.11.2 Products/Solutions/Services offered
        4.11.3 Recent developments

    4.12 ORION CORPORATION

        4.12.1 Business overview
        4.12.2 Products/Solutions/Services offered
        4.12.3 Recent developments

    4.13 NORBROOK

        4.13.1 Business overview
        4.13.2 Products/Solutions/Services offered
        4.13.3 Recent developments

    4.14 CEVA SANTE ANIMALE

        4.14.1 Business overview
        4.14.2 Products/Solutions/Services offered
        4.14.3 Recent developments

    4.15 BIMEDA, INC.

        4.15.1 Business overview
        4.15.2 Products/Solutions/Services offered
        4.15.3 Recent developments

    4.16 INDIAN IMMUNOLOGICALS LTD.

        4.16.1 Business overview
        4.16.2 Products/Solutions/Services offered
        4.16.3 Recent developments

    4.17 VETANCO

        4.17.1 Business overview
        4.17.2 Products/Solutions/Services offered
        4.17.3 Recent developments

    4.18 CHANELLE PHARMA

        4.18.1 Business overview
        4.18.2 Products/Solutions/Services offered
        4.18.3 Recent developments

    4.19 PEGASUS LABORATORIES, INC.

        4.19.1 Business overview
        4.19.2 Products/Solutions/Services offered
        4.19.3 Recent developments

    4.20 KYORITSU SEIYAKU CORPORATION

        4.20.1 Business overview
        4.20.2 Products/Solutions/Services offered
        4.20.3 Recent developments

    4.21 AVET HEALTH

        4.21.1 Business overview
        4.21.2 Products/Solutions/Services offered
        4.21.3 Recent developments

    4.22 ANIMALDERMA SRLS

        4.22.1 Business overview
        4.22.2 Products/Solutions/Services offered
        4.22.3 Recent developments

    4.23 LETI PHARMA

        4.23.1 Business overview
        4.23.2 Products/Solutions/Services offered
        4.23.3 Recent developments

    4.24 HUVEPHARMA, INC.

        4.24.1 Business overview
        4.24.2 Products/Solutions/Services offered
        4.24.3 Recent developments

    4.25 VETPLUS

        4.25.1 Business overview
        4.25.2 Products/Solutions/Services offered
        4.25.3 Recent developments